"Reports Monitor has a new report called" Global Essential Oils Market Professional Report 2021-2026 ”in its extensive database of research reports. The new...
Eli Lilly announced that its investigated GIP and GLP-1 inhibitor tirzepatide has demonstrated superiority over Novo Nordisk's Ozempic in a Phase III study.The SURPASS-2...